Le Lézard
Classified in: Health, Science and technology, Business
Subjects: SVY, LIC

SciBase initiates collaboration with Inderes for commissioned research


STOCKHOLM, Jan. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in early detection and prevention in dermatology initiates cooperation with Inderes (www.inderes.se) for ongoing services related to commissioned research. This collaboration aims at providing high-quality equity research on SciBase Holding AB stock.

The research reports, analyst comments and interview videos will be published and made available on inderes.se, inderes.dk and inderes.fi with over 70,000 active members, as well as through Inderes' channels on social media and other investor platforms. The first analysis is planned to be carried out in the first quarter of 2024. Inderes welcomes all investors to discuss and ask questions from the analyst on forum.inderes.se once the research is published.

The main purpose of the collaboration is to:

  1. Increase investor awareness of SciBase
  2. Help investors better understand SciBase
  3. Create a communication channel between the investors and SciBase
  4. Improve the price formation and liquidity of SciBase's stock

For additional information, please contact:

Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
Michael Colerus, CFO, tel. +46703413472, e-mail: [email protected]

Certified Advisor (CA):

Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]

About SciBase

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. All press-releases and financial reports can be found here : http://investors.scibase.se/en/pressreleases 

About Inderes

Inderes connects investors and listed companies, with the aim of democratizing information in the financial markets. Inderes helps over 400 Nordic listed companies to better serve their shareholders. Inderes' Nordic community consists of over 70,000 active investors.

The following files are available for download:

https://mb.cision.com/Main/12371/3917413/2568363.pdf

Inderes PR

 


These press releases may also interest you

at 21:05
On June 27, 2024, Yidu Tech Inc. (the ''Company'' or ''Yidu Tech'') (2158.HK), a leader in China's AI medical industry, announced its results for the 2024 fiscal year. During the reporting period, the Company recorded revenue of RMB 807.1 million....

at 21:05
Yidu Tech Inc. ("Yidu Tech" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group", HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 ("FY2024" or the "Reporting Period"). The...

at 20:00
CBC Group ("CBC"), Asia's largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its controlled portfolio company, Hasten Biopharmaceutical ("Hasten"), an innovation-driven biopharmaceutical company, has...

at 19:01
The announcement of the snap UK general election in May prompted nearly a third of Brits to alter their holiday plans, according to new consumer research from Travel Counsellors, the UK's largest and...

at 15:30
Ellomay Capital Ltd. ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited financial results for the three month period...

at 12:28
Phase two of ambitious Jafurah gas development commences with award of contracts worth around $12.4bnContracts worth around $8.8bn awarded for phase three expansion of Company's Master Gas System23 additional unconventional gas rig contracts valued...



News published on and distributed by: